On behalf of the more than 50 million adults and 300,000 children in the United States with doctor-diagnosed arthritis, the Arthritis Foundation appreciates the opportunity to provide comments to ICER on the selected topic of rheumatoid arthritis (RA). RA is a complex chronic disease that can be difficult to treat, and people who suffer from the disease require regular, ongoing professional care. Further, a treatment that works well in one person might not work in another person with the seemingly identical disease characteristics, so patient access to the full range of treatment options is also critically important. The Arthritis Foundation also believes robust stakeholder engagement is a critical component of any evaluation that will have a direct impact on people with arthritis and the providers who treat them. We want our comments to inform ICER’s process and help ensure that the final report reflects the complexity of the disease and the needs of the people who suffer from it.
Read the full letter at Arthritis.org